178 related articles for article (PubMed ID: 10634368)
1. Antiandrogen drugs lower serum prostate-specific antigen (PSA) levels in hirsute subjects: evidence that serum PSA is a marker of androgen action in women.
Negri C; Tosi F; Dorizzi R; Fortunato A; Spiazzi GG; Muggeo M; Castello R; Moghetti P
J Clin Endocrinol Metab; 2000 Jan; 85(1):81-4. PubMed ID: 10634368
[TBL] [Abstract][Full Text] [Related]
2. High serum prostate-specific antigen concentrations in hirsute women do not decrease with treatment by the combination of spironolactone and the contraceptive pill.
Guzelmeric K; Seker N; Unal O; Turan C
Gynecol Endocrinol; 2004 Oct; 19(4):190-5. PubMed ID: 15724801
[TBL] [Abstract][Full Text] [Related]
3. Prostate-specific antigen in female serum, a potential new marker of androgen excess.
Melegos DN; Yu H; Ashok M; Wang C; Stanczyk F; Diamandis EP
J Clin Endocrinol Metab; 1997 Mar; 82(3):777-80. PubMed ID: 9062481
[TBL] [Abstract][Full Text] [Related]
4. Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial.
Moghetti P; Tosi F; Tosti A; Negri C; Misciali C; Perrone F; Caputo M; Muggeo M; Castello R
J Clin Endocrinol Metab; 2000 Jan; 85(1):89-94. PubMed ID: 10634370
[TBL] [Abstract][Full Text] [Related]
5. Serum prostate-specific antigen concentrations are not useful for monitoring the treatment of hirsutism with oral contraceptive pills.
Escobar-Morreale HF; Avila S; Sancho J
J Clin Endocrinol Metab; 2000 Jul; 85(7):2488-92. PubMed ID: 10902798
[TBL] [Abstract][Full Text] [Related]
6. Serum prostate specific antigen levels in women with polycystic ovary syndrome and the effect of flutamide+desogestrel/ethinyl estradiol combination.
Bahceci M; Bilge M; Tuzcu A; Tuzcu S; Bahceci S
J Endocrinol Invest; 2004 Apr; 27(4):353-6. PubMed ID: 15233555
[TBL] [Abstract][Full Text] [Related]
7. Effect of finasteride on serum levels of androstenedione, testosterone and their 5α-reduced metabolites in men at risk for prostate cancer.
Stanczyk FZ; Azen CG; Pike MC
J Steroid Biochem Mol Biol; 2013 Nov; 138():10-6. PubMed ID: 23474436
[TBL] [Abstract][Full Text] [Related]
8. Comparison of finasteride and flutamide in the treatment of idiopathic hirsutism.
Falsetti L; Gambera A
Fertil Steril; 1999 Jul; 72(1):41-6. PubMed ID: 10428146
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of 3alpha-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects.
Meczekalski B; Slopien R; Warenik-Szymankiewicz A
Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):88-92. PubMed ID: 16979812
[TBL] [Abstract][Full Text] [Related]
10. Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism.
Carmina E; Lobo RA
Obstet Gynecol; 1991 Nov; 78(5 Pt 1):845-9. PubMed ID: 1833685
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of prostate-specific antigen and androgens after nasal administration of a gonadotropin releasing hormone-agonist in hirsute women.
Kocak M; Tarcan A; Beydilli G; Koç S; Haberal A
Gynecol Endocrinol; 2004 Apr; 18(4):179-85. PubMed ID: 15293888
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of androstanediol glucuronide, total testosterone, and free testosterone in hirsute women.
Khoury MY; Baracat EC; Pardini DP; Vieira JG; de Lima GR
Fertil Steril; 1994 Jul; 62(1):76-80. PubMed ID: 8005308
[TBL] [Abstract][Full Text] [Related]
13. Treatment of hirsutism: comparisons between different antiandrogens with central and peripheral effects.
Fruzzetti F; Bersi C; Parrini D; Ricci C; Genazzani AR
Fertil Steril; 1999 Mar; 71(3):445-51. PubMed ID: 10065780
[TBL] [Abstract][Full Text] [Related]
14. Androgen sulfate and glucuronide conjugates in nonhirsute and hirsute women with polycystic ovarian syndrome.
Matteri RK; Stanczyk FZ; Gentzschein EE; Delgado C; Lobo RA
Am J Obstet Gynecol; 1989 Dec; 161(6 Pt 1):1704-9. PubMed ID: 2532471
[TBL] [Abstract][Full Text] [Related]
15. Serum prostate-specific antigen concentration is increased in acromegalic women.
Manetti L; Lupi I; Genovesi M; Morselli L; Grasso L; Nencetti C; Gasperi M; Bogazzi F; Bartalena L; Martino E
J Endocrinol Invest; 2004; 27(7):643-7. PubMed ID: 15505987
[TBL] [Abstract][Full Text] [Related]
16. A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women.
Wong IL; Morris RS; Chang L; Spahn MA; Stanczyk FZ; Lobo RA
J Clin Endocrinol Metab; 1995 Jan; 80(1):233-8. PubMed ID: 7829618
[TBL] [Abstract][Full Text] [Related]
17. Effects of finasteride, a 5 alpha-reductase inhibitor, on circulating androgens and gonadotropin secretion in hirsute women.
Fruzzetti F; de Lorenzo D; Parrini D; Ricci C
J Clin Endocrinol Metab; 1994 Sep; 79(3):831-5. PubMed ID: 8077369
[TBL] [Abstract][Full Text] [Related]
18. Comparison of finasteride versus flutamide in the treatment of hirsutism.
Falsetti L; Gambera A; Legrenzi L; Iacobello C; Bugari G
Eur J Endocrinol; 1999 Oct; 141(4):361-7. PubMed ID: 10526249
[TBL] [Abstract][Full Text] [Related]
19. Normal and elevated 3 alpha-androstanediol glucuronide concentrations in women with various causes of hirsutism and its correlation with degree of hirsutism and androgen levels.
Pang S; Wang M; Jeffries S; Riddick L; Clark A; Estrada E
J Clin Endocrinol Metab; 1992 Jul; 75(1):243-8. PubMed ID: 1535633
[TBL] [Abstract][Full Text] [Related]
20. Undetectable prostate specific antigen at 6-12 months: a new marker for early success in hormonally treated patients after prostate brachytherapy.
Miller N; Smolkin ME; Bissonette E; Theodorescu D
Cancer; 2005 Jun; 103(12):2499-506. PubMed ID: 15852361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
